Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis

International Journal of Rheumatic Diseases

Volumn 13, Issue 3, 2010, Pages 240-245

  Nas, Kemal ^a   Yildirim, Kadir ^b   Cevik, Remzi ^a   Karatay, Saliha ^b   Erdal, Akin ^b   Baysal, Ozlem ^c   Altay, Zuhal ^c   Kamanli, Ayhan ^d   Ersoy, Yuksel ^c   Kaya, Arzu ^d   Durmus, Bekir ^c   Ardicoglu, Ozge ^d   Tekeoglu, Ibrahim ^e   Ugur, Mahir ^b   Sarac, Aysegul Jale ^a   Senel, Kazim ^b   Gur, Ali ^f   Ozgocmen, Salih ^g  

^a DICLE UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c INONU UNIVERSITY   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

^e YUZUNCU YIL UNIVERSITY   (Turkey)

^f GAZIANTEP UNIVERSITY   (Turkey)

^g ERCIYES UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; ASDAS; Disease activity

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; ASSESSMENT OF SPONDYLOARTHRITIS INTERNATIONAL SOCIETY; BACKACHE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CORRELATION ANALYSIS; DATA BASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORNING STIFFNESS; PRIORITY JOURNAL; RATING SCALE; REMISSION; UNIVERSITY HOSPITAL;

ADULT; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DATABASES AS TOPIC; DISCRIMINANT ANALYSIS; FEMALE; HEALTH STATUS INDICATORS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; SELF REPORT; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TURKEY;

EID: 77955386556     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01537.x     Document Type: Article

References (17)

1. Song IH, Rudwaleit M, Listing J, Sieper J. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations. Ann Rheum Dis 2009, 68:1701-7.
2. van der Linden S, van der Heijde D. Ankylosing spondylitis. Clinical features. Rheum Dis Clin North Am 1998, 24:663-76.
3. Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 2004, 51:154-9.
4. Lukas C, Landewe R, Sieper J. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68:18-24.
5. Spoorenberg A, van Tubergen A, Landewe R. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 2005, 44:789-95.
6. Ozgocmen S, Godekmerdan A, Ozkurt-Zengin F. Acute-phase response, clinical measures and disease activity in ankylosing spondylitis. Joint Bone Spine 2007, 74:249-53.
7. van der Heijde D, Lie E, Kvien TK. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68:1811-8.
8. Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 2004, 63:665-70.
9. Rudwaleit M, Claudepierre P, Wordsworth P. Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol 2009, 36:801-8.
10. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-8.
11. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994, 21:1694-8.
12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994, 21:2286-91.
13. Calin A, Garrett S, Whitelock H. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994, 21:2281-5.
14. Doward LC, Spoorenberg A, Cook SA. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003, 62:20-6.
15. Duruoz MT, Doward L, Cerrahoglu L. Ankilozan spondilit yaşam kalitesi olcutunun (ASQOL) Turkce gecerliligi ve guvenilirliligi. 2008, Antalya 50
16. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001, 44:1876-86.
17. Pedersen SJ, Sorensen IJ, Hermann KG. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS), and clinical and magnetic resonance imaging measures of disease activity in a 1 year follow-up study of patients with axial spondyloarthritis treated with TNF-{alpha} inhibitors. Ann Rheum Dis 2009, http://dx.doi.org/10.1136/ard.2009.111187, doi: [E-pub ahead of print]